Detalhe da pesquisa
1.
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.
Gastroenterology
; 166(2): 298-312.e14, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913894
2.
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression.
Gut
; 71(12): 2561-2573, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365570
3.
BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire.
Nucleic Acids Res
; 45(1): 127-141, 2017 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651452
4.
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer.
Clin Epigenetics
; 14(1): 7, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016723
5.
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.
Cell Death Dis
; 13(9): 762, 2022 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057630
6.
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Cell Death Dis
; 12(12): 1118, 2021 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845197
7.
Aberrant NFATc1 signaling counteracts TGFß-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Cell Death Dis
; 10(6): 446, 2019 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171768
8.
CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.
Oncotarget
; 7(39): 63730-63746, 2016 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27572314